Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 29 of 29 entries
Sorted by: Best Match Show Resources per page
Corrigendum to "Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles" [Eur. J. Pharm. Biopharm. 116 (2017) 17-30].

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Manjili HK, Ghasemi P, Malvandi H, Mousavi MS, Attari E, Danafar H.
PMID: 31470966
Eur J Pharm Biopharm. 2019 Sep;142:280. doi: 10.1016/j.ejpb.2019.06.023. Epub 2019 Jul 05.

No abstract available.

Cite
Manjili HK, Ghasemi P, Malvandi H, et al. Corrigendum to "Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles" [Eur. J. Pharm. Biopharm. 116 (2017) 17-30]. Eur J Pharm Biopharm. 2019;142:280doi: 10.1016/j.ejpb.2019.06.023.
Manjili, H. K., Ghasemi, P., Malvandi, H., Mousavi, M. S., Attari, E., & Danafar, H. (2019). Corrigendum to "Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles" [Eur. J. Pharm. Biopharm. 116 (2017) 17-30]. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 142280. https://doi.org/10.1016/j.ejpb.2019.06.023
Manjili, Hamidreza Kheiri, et al. "Corrigendum to "Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles" [Eur. J. Pharm. Biopharm. 116 (2017) 17-30]." European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V vol. 142 (2019): 280. doi: https://doi.org/10.1016/j.ejpb.2019.06.023
Manjili HK, Ghasemi P, Malvandi H, Mousavi MS, Attari E, Danafar H. Corrigendum to "Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles" [Eur. J. Pharm. Biopharm. 116 (2017) 17-30]. Eur J Pharm Biopharm. 2019 Sep;142:280. doi: 10.1016/j.ejpb.2019.06.023. Epub 2019 Jul 05. PMID: 31470966.
Copy Download .nbib Format: NLM
Can Fine Needle Aspiration Cytology be Used as a "Proxy Gold Standard" to Diagnose Tuberculous Mastitis?.

Journal of cytology

Kamal MM, Kulkarni HR, Makde MM, Munje R.
PMID: 30089945
J Cytol. 2018 Jul-Sep;35(3):159-162. doi: 10.4103/JOC.JOC_72_17.

OBJECTIVE: To assess the performance of fine needle aspiration cytology (FNAC) in the diagnosis of tuberculosis mastitis.MATERIALS AND METHODS: Diagnostic test performance evaluation using two methods-as compared to an alloyed gold standard as well as in the absence of...

Cite
Kamal MM, Kulkarni HR, Makde MM, et al. Can Fine Needle Aspiration Cytology be Used as a "Proxy Gold Standard" to Diagnose Tuberculous Mastitis?. J Cytol. 2018;35(3):159-162doi: 10.4103/JOC.JOC_72_17.
Kamal, M. M., Kulkarni, H. R., Makde, M. M., & Munje, R. (2018). Can Fine Needle Aspiration Cytology be Used as a "Proxy Gold Standard" to Diagnose Tuberculous Mastitis?. Journal of cytology, 35(3), 159-162. https://doi.org/10.4103/JOC.JOC_72_17
Kamal, Meherbano M, et al. "Can Fine Needle Aspiration Cytology be Used as a "Proxy Gold Standard" to Diagnose Tuberculous Mastitis?." Journal of cytology vol. 35,3 (2018): 159-162. doi: https://doi.org/10.4103/JOC.JOC_72_17
Kamal MM, Kulkarni HR, Makde MM, Munje R. Can Fine Needle Aspiration Cytology be Used as a "Proxy Gold Standard" to Diagnose Tuberculous Mastitis?. J Cytol. 2018 Jul-Sep;35(3):159-162. doi: 10.4103/JOC.JOC_72_17. PMID: 30089945; PMCID: PMC6060579.
Copy Download .nbib Format: NLM
CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario.

Indian journal of surgical oncology

Sankaran S, Dikshit JB, Prakash Sv C, Mallikarjuna SE, Somashekhar SP, Patil S, Kumar R, Prasad K, Shet D, Bakre MM.
PMID: 33994724
Indian J Surg Oncol. 2021 Apr;12:21-29. doi: 10.1007/s13193-019-01014-4. Epub 2019 Dec 09.

CanAssist Breast (CAB) has thus far been validated on a retrospective cohort of 1123 patients who are mostly Indians. Distant metastasis-free survival (DMFS) of more than 95% was observed with significant separation (

Cite
Sankaran S, Dikshit JB, Prakash Sv C, et al. CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario. Indian J Surg Oncol. 2019;12:21-29doi: 10.1007/s13193-019-01014-4.
Sankaran, S., Dikshit, J. B., Prakash Sv, C., Mallikarjuna, S. E., Somashekhar, S. P., Patil, S., Kumar, R., Prasad, K., Shet, D., & Bakre, M. M. (2021). CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario. Indian journal of surgical oncology, 1221-29. https://doi.org/10.1007/s13193-019-01014-4
Sankaran, Satish, et al. "CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario." Indian journal of surgical oncology vol. 12 (2021): 21-29. doi: https://doi.org/10.1007/s13193-019-01014-4
Sankaran S, Dikshit JB, Prakash Sv C, Mallikarjuna SE, Somashekhar SP, Patil S, Kumar R, Prasad K, Shet D, Bakre MM. CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR+ Breast Cancer Patients: Indian Scenario. Indian J Surg Oncol. 2021 Apr;12:21-29. doi: 10.1007/s13193-019-01014-4. Epub 2019 Dec 09. PMID: 33994724; PMCID: PMC8119549.
Copy Download .nbib Format: NLM
Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways.

Seminars in cancer biology

Manjili MH, Khazaie K.
PMID: 34990835
Semin Cancer Biol. 2022 Jan 03; doi: 10.1016/j.semcancer.2021.12.008. Epub 2022 Jan 03.

In this thematic issue, several mechanisms of tumor dormancy and relapse are discussed. The reviews suggest mutual interactions and communications between malignant cells and other cells in their niche during tumor dormancy. Nevertheless, a complete understanding of tumor dormancy...

Cite
Manjili MH, Khazaie K. Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways. Semin Cancer Biol. 2022;doi: 10.1016/j.semcancer.2021.12.008.
Manjili, M. H., & Khazaie, K. (2022). Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways. Seminars in cancer biology, . https://doi.org/10.1016/j.semcancer.2021.12.008
Manjili, Masoud H, and Khazaie, Khashayarsha. "Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways." Seminars in cancer biology vol. (2022). doi: https://doi.org/10.1016/j.semcancer.2021.12.008
Manjili MH, Khazaie K. Pattern recognition of tumor dormancy and relapse beyond cell-intrinsic and cell-extrinsic pathways. Semin Cancer Biol. 2022 Jan 03; doi: 10.1016/j.semcancer.2021.12.008. Epub 2022 Jan 03. PMID: 34990835.
Copy Download .nbib Format: NLM
Validation of CanAssist Breast immunohistochemistry biomarkers on an automated platform and its applicability in tissue microarray.

International journal of clinical and experimental pathology

Serkad CPV, Attuluri AK, Basavaraj C, Adinarayan M, Krishnamoorthy N, Ananthamurthy SB, Mallikarjuna SE, Bakre MM.
PMID: 34760037
Int J Clin Exp Pathol. 2021 Oct 15;14(10):1013-1021. eCollection 2021.

CanAssist Breast (CAB) is a prognostic test for early-stage hormone receptor-positive invasive breast cancer. The test involves performing immunohistochemical (IHC) analysis for five biomarkers, namely CD44, ABCC4, ABCC11, N-cadherin, and pan-cadherin. In addition to IHC grading information, three clinical...

Cite
Serkad CPV, Attuluri AK, Basavaraj C, et al. Validation of CanAssist Breast immunohistochemistry biomarkers on an automated platform and its applicability in tissue microarray. Int J Clin Exp Pathol. 2021;14(10):1013-1021
Serkad, C. P. V., Attuluri, A. K., Basavaraj, C., Adinarayan, M., Krishnamoorthy, N., Ananthamurthy, S. B., Mallikarjuna, S. E., & Bakre, M. M. (2021). Validation of CanAssist Breast immunohistochemistry biomarkers on an automated platform and its applicability in tissue microarray. International journal of clinical and experimental pathology, 14(10), 1013-1021.
Serkad, Chandra Prakash V, et al. "Validation of CanAssist Breast immunohistochemistry biomarkers on an automated platform and its applicability in tissue microarray." International journal of clinical and experimental pathology vol. 14,10 (2021): 1013-1021.
Serkad CPV, Attuluri AK, Basavaraj C, Adinarayan M, Krishnamoorthy N, Ananthamurthy SB, Mallikarjuna SE, Bakre MM. Validation of CanAssist Breast immunohistochemistry biomarkers on an automated platform and its applicability in tissue microarray. Int J Clin Exp Pathol. 2021 Oct 15;14(10):1013-1021. eCollection 2021. PMID: 34760037; PMCID: PMC8569307.
Copy Download .nbib Format: NLM
Showing 25 to 29 of 29 entries